Daratumumab
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. (NCT05835726) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2022-01-01 |
| Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma (NCT04065308) | Seoul National University Hospital | 2019-01-14 |
Track Daratumumab automatically
Every clearance here is in the API, with alerts when new ones post.